4//SEC Filing
Schwarzer Fred 4
Accession 0001209191-23-032304
CIK 0001496323other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 7:22 PM ET
Size
10.0 KB
Accession
0001209191-23-032304
Insider Transaction Report
Form 4
Schwarzer Fred
DirectorCEO and President
Transactions
- Sale
Common Stock
2023-05-23$13.01/sh−15$195→ 121,761 total - Sale
Common Stock
2023-05-23$12.30/sh−1,244$15,302→ 121,776 total - Award
Common Stock
2023-05-15$11.71/sh+960$11,242→ 123,020 total
Holdings
- 196,718(indirect: See footnote)
Common Stock
Footnotes (5)
- [F1]The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F3]This transaction was executed in multiple trades at prices ranging from $12.00 to $12.95. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]This transaction was executed in multiple trades at prices ranging from $13.00 to $13.02. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F5]The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.
Documents
Issuer
IGM Biosciences, Inc.
CIK 0001496323
Entity typeother
Related Parties
1- filerCIK 0001787361
Filing Metadata
- Form type
- 4
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 7:22 PM ET
- Size
- 10.0 KB